# Co-diagnostics (CODX) — Earnings

CODX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/codx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$1.46 |
| EPS estimate | −$3.00 |
| EPS surprise | +51.33% |
| Revenue surprise | +25.31% |
| Revenue | $166,131.00 |
| Revenue estimate | $132,576.00 |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1692415/000149315226037762/form10-q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/de141c3e-461e-45ba-775d-427f764f1a0f.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$3.00 | −$1.46 | 51.33% | $132,576.00 | $166,131.00 |
| Q1 2026 | May 14, 2026 | −$3.75 | −$4.06 | -8.27% | $127,052.00 | $145,954.00 |
| Q4 2025 | Mar 31, 2026 | −$3.60 | −$16.35 | -354.17% | $125,883.00 | $262,489.00 |
| Q3 2025 | Nov 13, 2025 | −$5.70 | −$4.80 | 15.79% | $300,000.00 | $145,380.00 |
| Q2 2025 | Aug 14, 2025 | −$7.50 | −$6.90 | 8.00% | $300,000.00 | $162,910.00 |
| Q1 2025 | May 8, 2025 | −$8.10 | −$7.20 | 11.11% | $200,000.00 | $50,277.00 |
| Q4 2024 | Mar 27, 2025 | −$10.20 | −$10.80 | -5.88% | $375,000.00 | $149,325.00 |
| Q3 2024 | Nov 7, 2024 | −$9.90 | −$9.60 | 3.03% | $375,000.00 | $641,141.00 |
| Q2 2024 | Aug 8, 2024 | −$10.20 | −$7.50 | 26.47% | $400,000.00 | $2.7M |
| Q1 2024 | May 9, 2024 | −$6.30 | −$9.30 | -47.62% | $3.1M | $500,000.00 |

## Frequently Asked Questions

### When did Co-diagnostics (CODX) last report earnings?

Co-diagnostics last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did CODX beat earnings estimates?

Yes. Co-diagnostics reported EPS of −$1.46 for Q2 2026 against a −$3.00 estimate — a 51.33% beat.

### How much revenue did CODX report last quarter?

Co-diagnostics reported $166,131.00 in revenue for Q2 2026, against a consensus estimate of $132,576.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).